Genotypic and phenotypic characterisation of a nosocomial outbreak of Candida auris in Spain during 5 years
- PMID: 39086009
- DOI: 10.1111/myc.13776
Genotypic and phenotypic characterisation of a nosocomial outbreak of Candida auris in Spain during 5 years
Abstract
Objectives: The investigation of Candida auris outbreaks is needed to provide insights into its population structure and transmission dynamics. We genotypically and phenotypically characterised a C. auris nosocomial outbreak occurred in Consorcio Hospital General Universitario de Valencia (CHGUV), Spain.
Methods: Data and isolates were collected from CHGUV from September 2017 (first case) until September 2021. Thirty-five isolates, including one from an environmental source, were randomly selected for whole genome sequencing (WGS), and the genomes were analysed along with a database with 335 publicly available genomes, assigning them to one of the five major clades. In order to identify polymorphisms associated with drug resistance, we used the fully susceptible GCA_003014415.1 strain as reference sequence. Known mutations in genes ERG11 and FKS1 conferring resistance to fluconazole and echinocandins, respectively, were investigated. Isolates were classified into aggregating or non-aggregating.
Results: All isolates belonged to clade III and were from an outbreak with a single origin. They clustered close to three publicly available genomes from a hospital from where the first patient was transferred, being the probable origin. The mutation VF125AL in the ERG11 gene, conferring resistance to fluconazole, was present in all the isolates and one isolate also carried the mutation S639Y in the FKS1 gene. All the isolates had a non-aggregating phenotype (potentially more virulent).
Conclusions: Isolates are genotypically related and phenotypically identical but one with resistance to echinocandins, which seems to indicate that they all belong to an outbreak originated from a single isolate, remaining largely invariable over the years. This result stresses the importance of implementing infection control practices as soon as the first case is detected or when a patient is transferred from a setting with known cases.
Keywords: Candida auris; candidaemia; clinical mycology; fluconazole resistance; molecular epidemiology; phylogenetic analysis.
© 2024 The Author(s). Mycoses published by Wiley‐VCH GmbH.
Similar articles
-
Emergence of the novel sixth Candida auris Clade VI in Bangladesh.Microbiol Spectr. 2024 Jul 2;12(7):e0354023. doi: 10.1128/spectrum.03540-23. Epub 2024 Jun 6. Microbiol Spectr. 2024. PMID: 38842332 Free PMC article.
-
Tracing the Evolutionary History and Global Expansion of Candida auris Using Population Genomic Analyses.mBio. 2020 Apr 28;11(2):e03364-19. doi: 10.1128/mBio.03364-19. mBio. 2020. PMID: 32345637 Free PMC article.
-
Detection and characterisation of a sixth Candida auris clade in Singapore: a genomic and phenotypic study.Lancet Microbe. 2024 Sep;5(9):100878. doi: 10.1016/S2666-5247(24)00101-0. Epub 2024 Jul 13. Lancet Microbe. 2024. PMID: 39008997
-
How does antifungal resistance vary in Candida (Candidozyma) auris and its clades? Quantitative and qualitative analyses and their clinical implications.Clin Microbiol Infect. 2025 Jul;31(7):1146-1156. doi: 10.1016/j.cmi.2025.04.003. Epub 2025 Apr 9. Clin Microbiol Infect. 2025. PMID: 40216246 Review.
-
Candida auris: report of an outbreak.Enferm Infecc Microbiol Clin (Engl Ed). 2020 Jan;38 Suppl 1:39-44. doi: 10.1016/j.eimc.2020.02.007. Enferm Infecc Microbiol Clin (Engl Ed). 2020. PMID: 32111364 Review. English, Spanish.
Cited by
-
Short-term evolution and dispersal patterns of fluconazole-resistance in Candida auris clade III.mBio. 2025 Feb 5;16(2):e0316424. doi: 10.1128/mbio.03164-24. Epub 2024 Dec 27. mBio. 2025. PMID: 39727422 Free PMC article.
-
Pathogenicity Evaluation on Fluconazole-Resistant Candida auris Clade V in Murine Model.Mycopathologia. 2025 Jun 24;190(4):58. doi: 10.1007/s11046-025-00963-5. Mycopathologia. 2025. PMID: 40555808
References
REFERENCES
-
- Satoh K, Makimura K, Hasumi Y, Nishiyama Y, Uchida K, Yamaguchi H. Candida auris sp. nov., a novel ascomycetous yeast isolated from the external ear canal of an inpatient in a Japanese hospital. Microbiol Immunol. 2009;53(1):41‐44.
-
- Chowdhary A, Voss A, Meis JF. Multidrug‐resistant Candida auris: ‘new kid on the block’ in hospital‐associated infections? J Hosp Infect. 2016;94(3):209‐212.
-
- Kohlenberg A, Monnet DL, Plachouras D, et al. Increasing number of cases and outbreaks caused by Candida auris in the EU/EEA, 2020 to 2021. Euro Surveill. 2022;27(46):2200846.
-
- Lockhart SR, Etienne KA, Vallabhaneni S, et al. Simultaneous emergence of multidrug‐resistant Candida auris on 3 continents confirmed by whole‐genome sequencing and epidemiological analyses. Clin Infect Dis. 2017;64(2):134‐140.
-
- Spruijtenburg B, Badali H, Abastabar M, et al. Confirmation of fifth Candida auris clade by whole genome sequencing. Emerg Microbes Infect. 2022;11(1):2405‐2411.
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical